- Home
- CRGX vs ACIC Comparison
CRGX vs ACIC Comparison
Compare CRGX & ACIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- ACIC
- Stock Information
- Founded
- CRGX 2021
- ACIC 1999
- Country
- CRGX United States
- ACIC United States
- Employees
- CRGX N/A
- ACIC N/A
- Industry
- CRGX
- ACIC Property-Casualty Insurers
- Sector
- CRGX
- ACIC Finance
- Exchange
- CRGX Nasdaq
- ACIC Nasdaq
- Market Cap
- CRGX 190.0M
- ACIC 556.0M
- IPO Year
- CRGX 2023
- ACIC N/A
- Fundamental
- Price
- CRGX $4.60
- ACIC $11.05
- Analyst Decision
- CRGX Hold
- ACIC Buy
- Analyst Count
- CRGX 7
- ACIC 1
- Target Price
- CRGX $5.33
- ACIC $16.00
- AVG Volume (30 Days)
- CRGX 1.5M
- ACIC 270.6K
- Earning Date
- CRGX 08-11-2025
- ACIC 08-06-2025
- Dividend Yield
- CRGX N/A
- ACIC 4.59%
- EPS Growth
- CRGX N/A
- ACIC 3.21
- EPS
- CRGX N/A
- ACIC 1.49
- Revenue
- CRGX N/A
- ACIC $302,261,000.00
- Revenue This Year
- CRGX $57.81
- ACIC N/A
- Revenue Next Year
- CRGX N/A
- ACIC $37.63
- P/E Ratio
- CRGX N/A
- ACIC $7.29
- Revenue Growth
- CRGX N/A
- ACIC 23.92
- 52 Week Low
- CRGX $3.00
- ACIC $8.82
- 52 Week High
- CRGX $25.45
- ACIC $15.08
- Technical
- Relative Strength Index (RSI)
- CRGX 62.02
- ACIC 54.85
- Support Level
- CRGX $4.32
- ACIC $10.64
- Resistance Level
- CRGX $4.75
- ACIC $11.16
- Average True Range (ATR)
- CRGX 0.18
- ACIC 0.28
- MACD
- CRGX 0.03
- ACIC 0.07
- Stochastic Oscillator
- CRGX 77.17
- ACIC 84.07
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.